• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

TH Open . Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-C

tetano

Editor, Senior Moderator
TH Open


. 2022 Sep 12;6(3):e251-e256.
doi: 10.1055/a-1878-6806. eCollection 2022 Jul.
Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register


Daniela Poli[SUP] 1 [/SUP], Emilia Antonucci[SUP] 2 [/SUP], Walter Ageno[SUP] 3 [/SUP], Paolo Prandoni[SUP] 2 [/SUP], Giovanni Barillari[SUP] 4 [/SUP], Giuseppina Bitti[SUP] 5 [/SUP], Egidio Imbalzano[SUP] 6 [/SUP], Eugenio Bucherini[SUP] 7 [/SUP], Antonio Chistolini[SUP] 8 [/SUP], Vittorio Fregoni[SUP] 9 [/SUP], Silvia Galliazzo[SUP] 10 [/SUP], Alberto Gandolfo[SUP] 11 [/SUP], Elisa Grifoni[SUP] 12 [/SUP], Franco Mastroianni[SUP] 13 [/SUP], Serena Panarello[SUP] 14 [/SUP], Raffaele Pesavento[SUP] 15 [/SUP], Simona Pedrini[SUP] 16 [/SUP], Girolamo Sala[SUP] 17 [/SUP], Pasquale Pignatelli[SUP] 18 [/SUP], Paola Preti[SUP] 19 [/SUP], Federico Simonetti[SUP] 20 [/SUP], Piera Sivera[SUP] 21 [/SUP], Adriana Visonà[SUP] 22 [/SUP], Sabina Villalta[SUP] 23 [/SUP], Rossella Marcucci[SUP] 1 24 [/SUP], Gualtiero Palareti[SUP] 2 [/SUP]



Affiliations

Abstract

Background Coronavirus disease 2019 (COVID-19) infection causes acute respiratory insufficiency with severe interstitial pneumonia and extrapulmonary complications; in particular, it may predispose to thromboembolic disease. The reported incidence of thromboembolic complications varies from 5 to 30% of cases. Aim We conducted a multicenter, Italian, retrospective, observational study on COVID-19 patients admitted to ordinary wards, to describe the clinical characteristics of patients at admission and bleeding and thrombotic events occurring during the hospital stay. Results The number of hospitalized patients included in the START-COVID-19 Register was 1,135, and the number of hospitalized patients in ordinary wards included in the study was 1,091, with 653 (59.9%) being males and 71 years (interquartile range 59-82 years) being the median age. During the observation, two (0.2%) patients had acute coronary syndrome episodes and one patient (0.1%) had an ischemic stroke; no other arterial thrombotic events were recorded. Fifty-nine patients had symptomatic venous thromboembolism (VTE) (5.4%) events, 18 (30.5%) deep vein thrombosis (DVT), 39 (66.1%) pulmonary embolism (PE), and 2 (3.4%) DVT+PE. Among patients with DVT, eight (44.4%) were isolated distal DVT and two cases were jugular thrombosis. Among patients with PE, seven (17.9%) events were limited to subsegmental arteries. No fatal PE was recorded. Major bleeding events occurred in nine (1.2%) patients and clinically relevant nonmajor bleeding events in nine (1.2%) patients. All bleeding events occurred among patients receiving thromboprophylaxis, more frequently when treated with subtherapeutic or therapeutic dosages. Conclusion Our findings confirm that patients admitted to ordinary wards for COVID-19 infection are at high risk for thromboembolic events. VTE recorded among these patients is mainly isolated PE, suggesting a peculiar characteristic of VTE in these patients.

Keywords: COVID-19; bleeding; thromboprophylaxis; venous thromboembolism.
 
Back
Top Bottom